{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:18:05Z","timestamp":1767140285843,"version":"build-2238731810"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T00:00:00Z","timestamp":1481587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T00:00:00Z","timestamp":1481587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003491","name":"Herlev Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003491","id-type":"DOI","asserted-by":"crossref"}]},{"name":"L\u00e6geforeningens Forskningsfond"},{"name":"Mimi og Viktor Larsens Fond"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00520-016-3522-6","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T04:10:09Z","timestamp":1481602209000},"page":"1279-1289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["RETRACTED ARTICLE: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8857-8143","authenticated-orcid":false,"given":"Per Boye","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Penkowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,13]]},"reference":[{"key":"3522_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM et al (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Fran\u00e7ais du My\u00e9lome. N Engl J Med 335:91\u201397","journal-title":"N Engl J Med"},{"key":"3522_CR2","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE et al (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348:1875\u20131883","journal-title":"N Engl J Med"},{"key":"3522_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00520-013-1940-2","volume":"22","author":"LL Fernandes","year":"2014","unstructured":"Fernandes LL, Torres SR, Garnica M et al (2014) Oral status of patients submitted to autologous hematopoietic stem cell transplantation. Support Care Cancer 22:15\u201321","journal-title":"Support Care Cancer"},{"key":"3522_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1517\/14712598.2014.874412","volume":"14","author":"HR Wardill","year":"2014","unstructured":"Wardill HR, Bowen JM, Gibson RJ (2014) New pharmacotherapy options for chemotherapy-induced alimentary mucositis. Expert Opin Biol Ther 14:347\u2013354","journal-title":"Expert Opin Biol Ther"},{"key":"3522_CR5","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1016\/j.transproceed.2011.08.053","volume":"43","author":"A Wa\u015bko-Grabowska","year":"2011","unstructured":"Wa\u015bko-Grabowska A, Rzepecki P, Oborska S et al (2011) Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience. Transplant Proc 43:3111\u20133113","journal-title":"Transplant Proc"},{"key":"3522_CR6","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1056\/NEJMoa040125","volume":"351","author":"R Spielberger","year":"2004","unstructured":"Spielberger R, Stiff P, Bensinger W et al (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590\u20132598","journal-title":"N Engl J Med"},{"key":"3522_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/bmt.2013.118","volume":"49","author":"AH Herbers","year":"2014","unstructured":"Herbers AH, van der Velden WJ, de Haan AF et al (2014) Impact of palifermin on intestinal mucositis of HSCT recipients after BEAM. Bone Marrow Transplant 49:8\u201310","journal-title":"Bone Marrow Transplant"},{"key":"3522_CR8","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/bmt.2012.257","volume":"48","author":"N Blijlevens","year":"2013","unstructured":"Blijlevens N, de Ch\u00e2teau M, Krivan G et al (2013) In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient\u2019s burden. Bone Marrow Transplant 48:966\u2013971","journal-title":"Bone Marrow Transplant"},{"key":"3522_CR9","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1021\/cr980425s","volume":"99","author":"GG Briand","year":"1999","unstructured":"Briand GG, Burford N (1999) Bismuth compounds and preparations with biological or medicinal relevance. Chem Rev 99:2601\u20132658","journal-title":"Chem Rev"},{"key":"3522_CR10","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1039\/C3CC47644H","volume":"50","author":"W Xia","year":"2014","unstructured":"Xia W, Li H, Sun H (2014) Functional disruption of HypB, a GTPase of Helicobacter pylori, by bismuth. Chem Commun (Camb) 50:1611\u20131614","journal-title":"Chem Commun (Camb)"},{"key":"3522_CR11","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3748\/wjg.v20.i6.1517","volume":"20","author":"M Song","year":"2014","unstructured":"Song M, Ang TL (2014) Second and third line treatment options for Helicobacter pylori eradication. World J Gastroenterol 20:1517\u20131528","journal-title":"World J Gastroenterol"},{"key":"3522_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/978-3-0348-6784-9_70","volume":"52","author":"N Imura","year":"1987","unstructured":"Imura N, Naganuma A, Satoh M, Koyama Y (1987) Induction of renal metallothionein allows increasing dose of an extensively used antitumor drug, cis-diamminedichloroplatinum. Experientia Suppl 52:655\u2013660","journal-title":"Experientia Suppl"},{"key":"3522_CR13","first-page":"1138","volume":"25","author":"T Morikawa","year":"1990","unstructured":"Morikawa T, Kawamura E, Komiyama T, Imura N (1990) Alleviation of cisplatin toxicity by high-dose bismuth subnitrate and pharmacokinetics of bismuth subnitrate and cisplatin. Nippon Gan Chiryo Gakkai Shi 25:1138\u20131145","journal-title":"Nippon Gan Chiryo Gakkai Shi"},{"key":"3522_CR14","first-page":"1094","volume":"16","author":"T Morikawa","year":"1989","unstructured":"Morikawa T, Kawamura E (1989) A method of cisplatin administration with the aid of high-dose bismuth subnitrate, and their pharmacokinetics. Gan To Kagaku Ryoho 16:1094\u20131098","journal-title":"Gan To Kagaku Ryoho"},{"key":"3522_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1349-7006.1988.tb01605.x","volume":"79","author":"A Naganuma","year":"1988","unstructured":"Naganuma A, Satoh M, Imura N (1988) Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice. Jpn J Cancer Res 79:406\u2013411","journal-title":"Jpn J Cancer Res"},{"key":"3522_CR16","first-page":"2303","volume":"12","author":"Y Kondo","year":"1992","unstructured":"Kondo Y, Satoh M, Imura N, Akimoto M (1992) Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamminedichloroplatinum (II) against bladder tumor. Anticancer Res 12:2303\u20132307","journal-title":"Anticancer Res"},{"key":"3522_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF00686330","volume":"29","author":"Y Kondo","year":"1991","unstructured":"Kondo Y, Satoh M, Imura N, Akimoto M (1991) Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor. Cancer Chemother Pharmacol 29:19\u201323","journal-title":"Cancer Chemother Pharmacol"},{"key":"3522_CR18","first-page":"4767","volume":"53","author":"M Satoh","year":"1993","unstructured":"Satoh M, Kondo Y, Mita M et al (1993) Prevention of carcinogenicity of anticancer drugs by metallothionein induction. Cancer Res 53:4767\u20134768","journal-title":"Cancer Res"},{"key":"3522_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1124\/mol.52.2.195","volume":"52","author":"Y Kondo","year":"1997","unstructured":"Kondo Y, Rusnak JM, Hoyt DG et al (1997) Enhanced apoptosis in metallothionein null cells. Mol Pharmacol 52:195\u2013201","journal-title":"Mol Pharmacol"},{"key":"3522_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.proghi.2008.10.001","volume":"44","author":"M\u00d8 Pedersen","year":"2009","unstructured":"Pedersen M\u00d8, Larsen A, Stoltenberg M, Penkowa M (2009) The role of metallothioneinin oncogenesis and cancer prognosis. Prog Histochem Cytochem 44:29\u201364","journal-title":"Prog Histochem Cytochem"},{"key":"3522_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1039\/C3MT00132F","volume":"6","author":"M Raudenska","year":"2014","unstructured":"Raudenska M, Gumulec J, Podlaha O et al (2014) Metallothionein polymorphisms in pathological processes. Metallomics 6:55\u201368","journal-title":"Metallomics"},{"key":"3522_CR22","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.3390\/ijms14036044","volume":"14","author":"B Ruttkay-Nedecky","year":"2013","unstructured":"Ruttkay-Nedecky B, Nejdl L, Gumulec J et al (2013) The role of metallothionein in oxidative stress. Int J Mol Sci 14:6044\u20136066","journal-title":"Int J Mol Sci"},{"key":"3522_CR23","first-page":"301","volume":"21","author":"A Naganuma","year":"1994","unstructured":"Naganuma A, Imura N (1994) Role of metallothionein in cancer chemotherapy. Gan To Kagaku Ryoho 21:301\u2013306","journal-title":"Gan To Kagaku Ryoho"},{"key":"3522_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0024-3205(00)00667-6","volume":"67","author":"M Satoh","year":"2000","unstructured":"Satoh M, Naganuma A, Imura N (2000) Modulation of adriamycin toxicity by tissue-specific induction of metallothionein synthesis in mice. Life Sci 67:627\u2013634","journal-title":"Life Sci"},{"key":"3522_CR25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djj228","volume":"98","author":"PW Finch","year":"2006","unstructured":"Finch PW, Rubin JS (2006) Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J Natl Cancer Inst 98:812\u2013824","journal-title":"J Natl Cancer Inst"},{"key":"3522_CR26","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/jcmm.12091","volume":"17","author":"PW Finch","year":"2013","unstructured":"Finch PW, Mark Cross LJ, McAuley DF, Farrell CL (2013) Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models. J Cell Mol Med 17:1065\u20131087","journal-title":"J Cell Mol Med"},{"key":"3522_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbrc.2013.09.044","volume":"440","author":"R Ishino","year":"2013","unstructured":"Ishino R, Minami K, Tanaka S et al (2013) FGF7 supports hematopoietic stem and progenitor cells and niche-dependent myeloblastoma cells via autocrine action on bone marrow stromal cells in vitro. Biochem Biophys Res Commun 440:125\u2013131","journal-title":"Biochem Biophys Res Commun"},{"key":"3522_CR28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00520-005-0792-9","volume":"13","author":"S Vokurka","year":"2005","unstructured":"Vokurka S, Bystricka E, Koza V et al (2005) The comparative effects of povidone\u2013iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT\u2014results of a randomized multicentre study. Support Care Cancer 13:554\u2013558","journal-title":"Support Care Cancer"},{"key":"3522_CR29","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s00520-006-0031-z","volume":"14","author":"S Vokurka","year":"2006","unstructured":"Vokurka S, Bystrick\u00e1 E, Koza V et al (2006) Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study. Support Care Cancer 14:974\u2013976","journal-title":"Support Care Cancer"},{"key":"3522_CR30","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s00277-015-2437-5","volume":"94","author":"I Sakellari","year":"2015","unstructured":"Sakellari I, Angelopoulou M, Tsopra O et al (2015) A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation. Ann Hematol 94:1733\u20131740","journal-title":"Ann Hematol"},{"key":"3522_CR31","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1182\/blood-2013-07-517037","volume":"123","author":"M Pfreundschuh","year":"2014","unstructured":"Pfreundschuh M, M\u00fcller C, Zeynalova S et al (2014) Suboptimal dosing of rituximab in male and female patients with DLBCL. Blood 123:640\u2013646","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1007\/s00520-020-05770-w","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"record-id":"24231"},{"DOI":"10.1007\/s00520-020-05770-w","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000}}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3522-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-016-3522-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3522-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T20:16:50Z","timestamp":1606249010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-016-3522-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,13]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3522"],"URL":"https:\/\/doi.org\/10.1007\/s00520-016-3522-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,13]]},"assertion":[{"value":"28 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the retraction notice for more detail: https:\/\/doi.org\/10.1007\/s00520-020-05770-w.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by relevant boards including the ethics committee and the Danish National Board of Health. This study is registered with EudraCT number 2007-007652-34.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was funded by means of our institutions at the time of investigation (the Department of Hematology and the University of Copenhagen) and by grants from Herlev Hospital (PBH), L\u00e6geforeningens Forskningsfond (MP) and Mimi og Viktor Larsens Fond (MP).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}